Ultimovacs ASA: Mandatory notification of trade by primary insider
Oslo, 17 February 2022, Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs ASA, has today bought 1,000...
News
Resverlogix Expands Phase 2b Clinical Trial for COVID-19 Treatment with First Site in Brazil and Second in Canada
CALGARY, Alberta, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced that the first Brazilian site has...
Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through its COPE Program with InterVivo Solutions
TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"),...
Evelo Biosciences Announces Dosing of First Patient in Phase 2 Trial of EDP1815 in Atopic Dermatitis
CAMBRIDGE, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing SINTAX™ medicines...
Microbix Presenting at Capital Conference in B.C.
Meetings with Growth-Oriented Investors, February 18-20, 2022MISSISSAUGA, Ontario, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX:...
Tilray Launches Medical Cannabis Products in Malta
LEAMINGTON, Ontario, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a...
R1 RCM Reports Fourth Quarter and Full Year 2021 Results
MURRAY, Utah, Feb. 17, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that...
Syneos Health Reports Fourth Quarter and Full Year 2021 Results
Highlights Fourth quarter revenue of $1,373.4 million increased 20.5% year-over-year.Clinical Solutions net new business awards and book-to-bill ratios: Including reimbursable...
Awakn Life Sciences Drug Discovery Program Files Patent Application for a New Class of Entactogen-Like Molecules
Entactogen NCE Series Enhances the Potential to Treat a Broad Range of AddictionsToronto, Ontario--(Newsfile Corp. - February 17, 2022) -...
Verato and Particle Health Partner to Improve Interoperability and Data Efficacy for Healthcare and Technology Solutions
The Verato Universal MPI integrates with Particle Health’s intuitive API platform to improve data matching and aggregation across the care...
MEDITECH Brings Transformation in Motion to HIMSS22
Visit MEDITECH at booth #3311 and hear from clinician experts about how Expanse improves mobility, usability, and efficiency for their...
Emids Launches Extensive Rebranding Initiative
Company’s revitalized identity and core values capture its vision of human-centered healthcare innovation NASHVILLE, Tenn.--(BUSINESS WIRE)--Emids, the proven leader in...
EvoEndo Announces US FDA 510(k) Clearance for Single-Use Unsedated Transnasal Endoscopy (TNE) System
EvoEndo’s Single-Use Endoscopy System or the “EvoEndo System” eliminates the need for general anesthesia or conscious sedation during routine upper...
Covetrus Announces Fourth Quarter and Full-Year 2021 Earnings Release Date and Conference Call Information
PORTLAND, Maine--(BUSINESS WIRE)--$CVET #earnings--Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release...
NextGen Healthcare Partners with Verato to Enhance Patient Insights
Patient-Matching Technology within NextGen Health Data Hub Platform Offers Providers a More Complete Picture of Patient Health ATLANTA--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen...
Establishment Labs Reaches Two Million Motiva Implants Milestone
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,...
Gresham Worldwide, a BitNile Holdings Subsidiary, Booked New Orders Exceeding $10.2 Million in the Fourth Quarter of 2021
Strong operating performance continues to drive bookings momentum LAS VEGAS--(BUSINESS WIRE)--$AGH #AmosKohn--BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding...
Nanomerics Expands and Moves to New Laboratories
LONDON, UK / ACCESSWIRE / February 17, 2022 / Nanomerics Ltd., a private speciality pharmaceutical company and University College London...
Cloud DX Grants Stock Options
KITCHENER, ON / ACCESSWIRE / February 16, 2022 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), Cloud DX, ("the Company" or "Cloud DX) a...
Therapeutic Goods Administration of Australia Authorizes Moderna’s Covid-19 Vaccine in Children (6-11 Years)
CAMBRIDGE, MA / ACCESSWIRE / February 16, 2022 / Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics...